Pembrolizumab Monotherapy in Relapsed Hepatocellular Carcinoma Post Living Donor Liver Transplantation and Sorafenib

Abstract

• Page 1 of 3 • Citation: Nasr F, Al Ghoche A, Diab S, Maddah J, Mansour L, et al. (2018) Pembrolizumab Monotherapy in Relapsed Hepatocellular Carcinoma Post Living Donor Liver Transplantation and Sorafenib. Int J Oncol Res 1:009. Accepted: November 10, 2018; Published: November 12, 2018 Copyright: © 2018 Nasr F, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.